IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures

PHASE4CompletedINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Tonic-clonic Seizure
Interventions
DRUG

Keppra

The patient will receive 1 gram of Keppra added to 100ml diluent and will be infused over 15 minutes.

DRUG

Fosphenytoin

IV load will be dependant on dilantin level. If no dilantin is detected in the patient, the patient will receive 1 gram of IV Fosphenytoin infused at 15 mg/min or slower depending on vitals.

DRUG

Dilantin

IV load will be dependant on dilantin level. If no dilantin is detected in the patient, the patient will receive 1 gram of IV phenytoin infused at 25 mg/min or slower depending on vitals.

Trial Locations (1)

30303

Grady Memorial Hospital, Atlanta

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

lead

Emory University

OTHER